Kalyan Yarraguntla

Kalyan Yarraguntla, MD, MS is a Clinical Assistant Professor in the Department of Neurology at Wayne State University School of Medicine. His clinical practice focuses on neuroimmune disorders with expertise in managing complex immunotherapies for patients with multiple sclerosis and related conditions.

Education:

• M.B.B.S, N.R.I. Medical College and General Hospital, NTR University of Health Sciences, Chinakakani, Andhra Pradesh, India (2008)
• Masters in Neuroscience, University of Hartford, West Bloomfield, CT (2013)
• Neurology Residency, Detroit Medical Center and Wayne State University School of Medicine (2023)
• Multiple Sclerosis/Neuroimmunology Fellowship, University of Pittsburgh Medical Center (2024)

Dr. Yarraguntla's research focuses on multiple sclerosis, neuromyelitis optica, transverse myelitis, optic neuritis, neurosarcoidosis, and autoimmune encephalitis. His work explores neural pathways for symptoms and complications of MS and other demyelinating conditions, with emphasis on implementing targeted interventions. He employs advanced neuroimaging techniques to study these neuroimmune conditions and conducts clinical studies and immunomodulator clinical trials to improve patient outcomes.

His publication record demonstrates a strong focus on multiple sclerosis research, particularly examining fatigue mechanisms, racial disparities in disease presentation and progression, neuroimaging biomarkers, and treatment responses. His work spans neuroimaging techniques including MRI, diffusion tensor imaging, and proton magnetic resonance spectroscopy to investigate white matter changes, cortical atrophy, and neural integrity in MS patients.

Professional Affiliations:

• American Academy of Neurology
• American Committee for Treatment and Research in Multiple Sclerosis

Dr. Yarraguntla maintains an active clinical practice at Wayne State University School of Medicine, Department of Neurology, Suite 8D-UHC, 4201 St. Antoine, Detroit, MI 48201, with clinic appointments available at (313) 745-4275. His translational research bridges clinical observations with advanced neuroimaging to develop more targeted therapeutic approaches for patients with neuroimmune disorders.